Concepedia
Statistics
Publications
2
Citations
210
H-Index
Active since
2020
Affiliations
Array BioPharma (United States)(Current)
Janelle Taylor is an author at Array BioPharma (United States).
Publications per year
2020–2023
Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
Anita Kulukian, Patrice Lee, Janelle Taylor et al. · Molecular Cancer Therapeutics · 2020 · 196 citations
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer
Devra J. Olson, Janelle Taylor, Kelsi Willis et al. · Cancer Research Communications · 2023 · 14 citations · Full text
1–2 of 2